Press Room

PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.

PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.

As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.

PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.

GenePrism: Actionable Insights is a new physician-ordered test that analyzes all 59 "medically actionable" genes identified by the American College of Medical Genetics and Genomics.

The Environmental Working Group published its annual “Dirty Dozen” list, which ranks fruits and vegetables by most and least contaminated with pesticide residues. Greg Sears, PerkinElmer’s VP and GM of Chromatography, Mass Spectrometry and Food, weighs in on why pesticide analysis is a critical part of today’s food ecosystem.

Gary Harton, a member of the team focused on pre-implantation genetic testing at PerkinElmer, talks about the process for patients who undergo genetic testing for neurodegenerative diseases.

As with many sectors of the food market, the dairy and dairy product industry is evolving. A growing world population, rising standards of living in developing nations and increases in product variety are reshaping the industry.

Emerald Scientific awarded the "Emerald Test" badges to PerkinElmer, affirming our instruments' ability to accurately detect pesticides, heavy metals, residual solvents, terpenes and potency in cannabis.

Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative.

Dr. Linh Hoang, M.D., Ph.D., vice president of Reproductive Health, outlines why early detection of preeclamspia provides a valuable window of opportunity for vigilance and intervention.

In this "Bold Types" feature, CFO Jamey Mock highlights some of the ways PerkinElmer will look to drive future growth.

Drug development is facing change from both technological pressures, including the use of AI and machine learning, and new regulations, which are transforming the way electronic records are created and stored for clinical trials.

For cannabis and hemp analysis, the high sensitivity of the QSight 400 Series supports laboratories in meeting state and federal regulations, including California and Canada.

Monitoring of residues in food substances is critical to ensuring no products are sold that contain dangerous levels of pesticides. Testing for even the smallest amounts of contaminants requires innovative lab equipment to guarantee products meet strict regulatory requirements.

The test, designed for noninvasive prenatal screening for trisomies 21, 18, and 13, with Y chromosome testing as an optional marker, has been validated in an external clinical study in France.

David Wang, general manager of Informatics, explains how scientists can harness valuable information quickly to achieve better, faster outcomes—and expedite the drug discovery process—by taking "the 3Vs" into account.